Table 5. Presenting lymph node regions.
| Lymph node regions | Number of patients Total n=550 (%) | Number of patients with malignant diseasesa Total n=95 (%) |
|---|---|---|
| Head and neck (level I–III and V) | 254 (46.2) | 35 (13.8) |
| Supraclavicular (level IV) | 35 (6.4) | 12 (34.3) |
| Axilla | 53 (9.6) | 8 (15.1) |
| Inguinal | 41 (7.5) | 7 (17.1) |
| ⩾2 regions | 87 (15.8) | 30 (34.5) |
| Extranodalb | 80 (14.5) | 3 (3.8) |
a
Malignancy refers to presenting lymph node regions in patients with proven malignancy. Percentage refers to the number of malignant nodes over the total number of patients with lymph nodes in a particular region. For example: for head and neck, 35 out of 254 patients gives 13.8%.
b
Extranodal denotes ‘lumps’ not present in the peripheral palpable lymph node regions.